Oxidative stress in prehypertension: rationale for antioxidant clinical trials.
about
Prehypertension: Underlying pathology and therapeutic options.The association of the vanin-1 N131S variant with blood pressure is mediated by endoplasmic reticulum-associated degradation and loss of function.Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment.Central hemodynamics in prehypertension: effect of the β-adrenergic antagonist nebivolol.A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.The impact of valvular oxidative stress on the development of venous stasis ulcer valvular oxidative stress and venous ulcers.
P2860
Oxidative stress in prehypertension: rationale for antioxidant clinical trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oxidative stress in prehypertension: rationale for antioxidant clinical trials.
@en
Oxidative stress in prehypertension: rationale for antioxidant clinical trials.
@nl
type
label
Oxidative stress in prehypertension: rationale for antioxidant clinical trials.
@en
Oxidative stress in prehypertension: rationale for antioxidant clinical trials.
@nl
prefLabel
Oxidative stress in prehypertension: rationale for antioxidant clinical trials.
@en
Oxidative stress in prehypertension: rationale for antioxidant clinical trials.
@nl
P2093
P2860
P356
P1433
P1476
Oxidative stress in prehypertension: rationale for antioxidant clinical trials.
@en
P2093
Bobby Zachariah
Nandeesha Hanumanthappa
Sathiyapriya Viswanathan
Selvaraj Nambiar
Sridhar Gopalakrishna Magadi
P2860
P304
P356
10.1177/0003319708319781
P577
2008-09-15T00:00:00Z